|
Global Migraine Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Smoking Cessation Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Alcon Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Ulcerative Colitis Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Cervical Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Human Papilloma Virus Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Hospira Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Oncology Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
5000 |
Global |
$3,495.00 |
|
|
Global Gastrointestinal Symptoms Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Targacept Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Baxter Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Systemic Lupus Erythematosus Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Eli Lilly Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 |
Sep 1 2017 |
280 |
Global |
$1,995.00 |
|
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Musculoskeletal Symptoms Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Monsanto Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Metabolic Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
500 |
Global |
$2,995.00 |
|
|
Global Obesity Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Actavis Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Brain Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Clostridium difficile Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Transdermal Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
160 |
Global |
$1,995.00 |
|
|
Global Multiple Sclerosis Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Inflammatory Bowel Disease Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Syngenta Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
AstraZeneca Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
